32 related articles for article (PubMed ID: 11857524)
1. High-programmed death-1 levels on hepatitis C virus-specific T cells during acute infection are associated with viral persistence and require preservation of cognate antigen during chronic infection.
Rutebemberwa A; Ray SC; Astemborski J; Levine J; Liu L; Dowd KA; Clute S; Wang C; Korman A; Sette A; Sidney J; Pardoll DM; Cox AL
J Immunol; 2008 Dec; 181(12):8215-25. PubMed ID: 19050238
[TBL] [Abstract][Full Text] [Related]
2. Interferon-gamma is produced by CD8 T cells in response to HLA-A24-restricted hepatitis C virus epitopes after sustained virus loss.
Kobayashi K; Ishii M; Shiina M; Ueno Y; Kondo Y; Kanno A; Miyazaki Y; Yamamoto T; Kobayashi T; Niitsuma H; Kikumoto Y; Takizawa H; Shimosegawa T
Clin Exp Immunol; 2005 Jul; 141(1):81-8. PubMed ID: 15958073
[TBL] [Abstract][Full Text] [Related]
3. Hepatitis C virus evasion of adaptive immune responses: a model for viral persistence.
Burke KP; Cox AL
Immunol Res; 2010 Jul; 47(1-3):216-27. PubMed ID: 20066508
[TBL] [Abstract][Full Text] [Related]
4. Multigene tracking of quasispecies in viral persistence and clearance of hepatitis C virus.
Chen S; Wang YM
World J Gastroenterol; 2005 May; 11(19):2874-84. PubMed ID: 15902722
[TBL] [Abstract][Full Text] [Related]
5. Characterization of antigenic variants of hepatitis C virus in immune evasion.
Wang JH; Pianko MJ; Ke X; Herskovic A; Hershow R; Cotler SJ; Chen W; Chen ZW; Rong L
Virol J; 2011 Jul; 8():377. PubMed ID: 21801418
[TBL] [Abstract][Full Text] [Related]
6. Associations of HLA-A, HLA-B and HLA-C alleles frequency with prevalence of herpes simplex virus infections and diseases across global populations: implication for the development of an universal CD8+ T-cell epitope-based vaccine.
Samandary S; Kridane-Miledi H; Sandoval JS; Choudhury Z; Langa-Vives F; Spencer D; Chentoufi AA; Lemonnier FA; BenMohamed L
Hum Immunol; 2014 Aug; 75(8):715-29. PubMed ID: 24798939
[TBL] [Abstract][Full Text] [Related]
7. Hepatitis C virus infection: virus/host interactions.
Pawlotsky JM
J Viral Hepat; 1998 Sep; 5 Suppl 1():3-8. PubMed ID: 9795922
[TBL] [Abstract][Full Text] [Related]
8. Viral, host and interferon-related factors modulating the effect of interferon therapy for hepatitis C virus infection.
Hu KQ; Vierling JM; Redeker AG
J Viral Hepat; 2001 Jan; 8(1):1-18. PubMed ID: 11155147
[TBL] [Abstract][Full Text] [Related]
9. The viral clearance in interferon-treated chronic hepatitis C is associated with increased cytotoxic T cell frequencies.
Löhr HF; Schmitz D; Arenz M; Weyer S; Gerken G; Meyer zum Büschenfelde KH
J Hepatol; 1999 Sep; 31(3):407-15. PubMed ID: 10488697
[TBL] [Abstract][Full Text] [Related]
10. Effect of interferon-alpha therapy on epitope-specific cytotoxic T lymphocyte responses in hepatitis C virus-infected individuals.
Vertuani S; Bazzaro M; Gualandi G; Micheletti F; Marastoni M; Fortini C; Canella A; Marino M; Tomatis R; Traniello S; Gavioli R
Eur J Immunol; 2002 Jan; 32(1):144-54. PubMed ID: 11754355
[TBL] [Abstract][Full Text] [Related]
11. Relation between viral fitness and immune escape within the hepatitis C virus protease.
Söderholm J; Ahlén G; Kaul A; Frelin L; Alheim M; Barnfield C; Liljeström P; Weiland O; Milich DR; Bartenschlager R; Sällberg M
Gut; 2006 Feb; 55(2):266-74. PubMed ID: 16105887
[TBL] [Abstract][Full Text] [Related]
12. DCs pulsed with novel HLA-A2-restricted CTL epitopes against hepatitis C virus induced a broadly reactive anti-HCV-specific T lymphocyte response.
Guo Z; Zhang H; Rao H; Jiang D; Cong X; Feng B; Wang J; Wei L; Chen H
PLoS One; 2012; 7(6):e38390. PubMed ID: 22701633
[TBL] [Abstract][Full Text] [Related]
13. Genetic variability of hepatitis C virus non-structural protein 3 and virus-specific CD8+ response in patients with chronic hepatitis C.
López-Labrador FX; He XS; Berenguer M; Cheung RC; González-Candelas F; Wright TL; Greenberg HB
J Med Virol; 2004 Apr; 72(4):575-85. PubMed ID: 14981760
[TBL] [Abstract][Full Text] [Related]
14. Evolution of viral quasispecies in four dominant HlA-A2 restricted T cell epitopes is not a major reason for viral persistence in interferon-treated patients with chronic hepatitis C.
Pingel S; Weyer S; Galle PR; Löhr HF
J Med Virol; 2002 Apr; 66(4):472-80. PubMed ID: 11857524
[TBL] [Abstract][Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
